Omada Health (NASDAQ:OMDA) Price Target Raised to $30.00 at JPMorgan Chase & Co.

Omada Health (NASDAQ:OMDA) had its price target raised by analysts at JPMorgan Chase & Co. from $26.00 to $30.00 in a report released on Friday,Benzinga reports. The firm presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price objective points to a potential upside of 23.85% from the company’s previous close.

OMDA has been the subject of several other reports. Citizens Jmp lifted their target price on shares of Omada Health from $27.00 to $32.00 and gave the company a “market outperform” rating in a report on Friday. Wells Fargo & Company raised their price target on shares of Omada Health from $17.00 to $18.00 and gave the company an “equal weight” rating in a research report on Friday, May 8th. Wall Street Zen raised shares of Omada Health from a “hold” rating to a “buy” rating in a report on Saturday, August 8th. Robert W. Baird increased their target price on shares of Omada Health from $15.00 to $25.00 and gave the stock a “neutral” rating in a research note on Wednesday. Finally, Needham & Company LLC restated a “buy” rating and set a $28.00 target price on shares of Omada Health in a research report on Friday, May 8th. Eleven analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $26.50.

Omada Health Stock Down 0.6%

Shares of OMDA traded down $0.15 during mid-day trading on Friday, reaching $24.22. The company had a trading volume of 352,076 shares, compared to its average volume of 1,269,509. The stock has a market capitalization of $1.48 billion, a P/E ratio of 484.80 and a beta of 1.73. Omada Health has a 52-week low of $10.28 and a 52-week high of $26.92. The stock has a 50 day moving average of $20.87 and a two-hundred day moving average of $16.43.

Omada Health (NASDAQ:OMDA) last announced its quarterly earnings results on Thursday, August 6th. The company reported $0.08 earnings per share for the quarter, beating the consensus estimate of ($0.02) by $0.10. Omada Health had a return on equity of 2.67% and a net margin of 1.39%.The company had revenue of $87.83 million during the quarter, compared to analysts’ expectations of $80.93 million. On average, sell-side analysts expect that Omada Health will post -0.01 earnings per share for the current year.

Insider Activity at Omada Health

In other news, CFO Steven L. Cook sold 1,607 shares of the business’s stock in a transaction dated Tuesday, August 11th. The shares were sold at an average price of $25.01, for a total transaction of $40,191.07. Following the completion of the sale, the chief financial officer owned 187,209 shares of the company’s stock, valued at $4,682,097.09. The trade was a 0.85% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Sean P. Duffy sold 12,942 shares of the company’s stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $24.81, for a total transaction of $321,091.02. Following the transaction, the chief executive officer owned 411,861 shares of the company’s stock, valued at approximately $10,218,271.41. This trade represents a 3.05% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 254,726 shares of company stock worth $5,370,496 in the last quarter. 6.38% of the stock is owned by insiders.

Hedge Funds Weigh In On Omada Health

A number of hedge funds have recently made changes to their positions in the company. Raymond James Financial Inc. purchased a new position in shares of Omada Health in the second quarter valued at approximately $32,000. Bellevue Group AG lifted its holdings in Omada Health by 0.7% in the 3rd quarter. Bellevue Group AG now owns 251,791 shares of the company’s stock valued at $5,567,000 after purchasing an additional 1,791 shares in the last quarter. Quarry LP acquired a new stake in Omada Health during the 4th quarter worth $29,000. Barclays PLC grew its holdings in shares of Omada Health by 14.6% during the fourth quarter. Barclays PLC now owns 14,850 shares of the company’s stock worth $234,000 after buying an additional 1,888 shares in the last quarter. Finally, TD Waterhouse Canada Inc. purchased a new position in shares of Omada Health in the fourth quarter worth about $32,000.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.